January 21, 2015
Pfizer Inc. allegedly ripped off consumers by fraudulently getting its patent for blockbuster arthritis drug Celebrex reissued so as to bring "sham litigation" and keep generic versions of the drug off the market, according to a putative antitrust class action filed in Virginia federal court Wednesday.